Bridget Bax

Has grant

Reader in Rare Diseases

St George’s, University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bridget Bax is a Reader in Rare Diseases at St. George's, University of London. Her research focuses on mitochondrial neurogastrointestinal encephalomyopathy, as well as the biomarkers associated with rare diseases. Notable recent publications include studies on plasma metabolomics, virus transmission mechanisms, and clinical spectra of mitochondrial conditions. Dr. Bax is dedicated to advancing the understanding and treatment of rare diseases through her work.

Recent Grants

Grant: Close

Pre-clinical safety studies of erythrocyte encapsulated thymidine phosphorylase

Open Date: 2010-06-30

Close Date: 2012-01-30

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Jameel Inal

Professor of Immunobiology

London Metropolitan University

UNITED KINGDOM

View details

Dan Stratton

Lecturer Health Science

Open University

UNITED KINGDOM

View details

Sigrun Lange

UNITED KINGDOM

View details

Karin Kipper

Head of Therapeutic Drug Monitoring Unit

UNITED KINGDOM

View details

Kevin Blighe

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bridget Bax

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Untargeted Plasma Metabolomics Extends the Biomarker Profile of Mitochondrial Neurogastrointestinal Encephalomyopathy

A Coxsackievirus B1-mediated nonlytic Extracellular Vesicle-to-cell mechanism of virus transmission and its possible control through modulation of EV release

Hematopoietic stem cell transplantation with reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome

Biomarkers in Rare Diseases 2.0

Clinical spectrum of early onset “Mediterranean” (homozygous p. <scp>P131L</scp> mutation) mitochondrial neurogastrointestinal encephalomyopathy

Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes

Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy

Biomarkers in Rare Diseases

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by theMNGIEInternational Network

Erythrocytes as Carriers of Therapeutic Enzymes

Quantification of Plasma and Urine Thymidine and 2’-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy

Collaborators (5)

Jameel Inal

Dan Stratton

Sigrun Lange

Karin Kipper

Kevin Blighe

Make your next move.